Inventor · disambiguated record
Shari Pilon-Thomas
Also filed as: PILON-THOMAS SHARI · PILON-THOMAS SHARI A
6 granted patents·13 pending applications·18 citations·filing 2009–2023
77Inventor score
Top patents by PatentIndex Score
19 records- 0182US10449227B2Conjugates for immunotherapyH LEE MOFFITT CANCER CT & RES·Filed 2015·Granted Oct 22, 2019·2 cites·9 claims
- 0282US10130658B2Method of ex vivo enhancement of immune cell activity for cancer immunotherapy with a small molecule ablative compoundSINGER JAMIE·Filed 2015·Granted Nov 20, 2018·5 cites·26 claims
- 0378US12291724B2Tumor-infiltrating lymphocytes for adoptive cell therapyH LEE MOFFITT CANCER CT & RES·Filed 2022·Granted May 6, 2025·0 cites·25 claims
- 0477US11401506B2Enhanced expansion of tumor-infiltrating lymphocytes for adoptive cell therapyH LEE MOFFITT CANCER CT & RES·Filed 2018·Granted Aug 2, 2022·1 cites·15 claims
- 0577US8597946B2Enhanced dendritic cells for cancer immunotherapyMULE JAMES J·Filed 2009·Granted Dec 3, 2013·10 cites·13 claims
- 0671US2024041972A1Conjugates for immunotherapyH LEE MOFFITT CANCER CT & RES·Filed 2023·Application pending·0 cites
- 0768US11518980B2Tumor-infiltrating lymphocytes for adoptive cell therapyH LEE MOFFITT CANCER CT & RES·Filed 2019·Granted Dec 6, 2022·0 cites·22 claims
- 0868US2022340874A1Enhanced Expansion of Tumor-Infiltrating Lymphocytes for Adoptive Cell TherapyH LEE MOFFITT CANCER CT & RES·Filed 2022·Application pending·0 cites
- 0958US2020188472A1Conjugates for immunotherapyH LEE MOFFITT CANCER CT & RES·Filed 2019·Application pending·0 cites
- 1058US2025281539A1Methods of culturing tumor infiltrating lymphocytesH LEE MOFFITT CANCER CT & RES·Filed 2023·Application pending·0 cites
- 1157US2025177444A1Culture of tumor infiltrating lymphocytes from tumor digestH LEE MOFFITT CANCER CT & RES·Filed 2023·Application pending·0 cites
- 1255US2025302961A1Targeting myeloid-derived suppressor cells (mdscs) in bladder cancer to enhance efficacy of adoptive cell therapy (act)H LEE MOFFITT CANCER CT & RES·Filed 2023·Application pending·0 cites
- 1354US2025003954A1Universal til cytotoxicity assayH LEE MOFFITT CANCER CT & RES·Filed 2022·Application pending·0 cites
- 1454US2024218329A1Culture of tumor infiltrating lymphocytes from tumor digestH LEE MOFFITT CANCER CT & RES·Filed 2022·Application pending·0 cites
- 1550US2024156910A1Til enhancement via ex vivo stimulation with cd40 agonistsH LEE MOFFITT CANCER CT & RES·Filed 2022·Application pending·0 cites
- 1648US2022002673A1Culture of tumor infiltrating lymphocytes from tumor digestMULLINAX JOHN ELLIS·Filed 2019·Application pending·0 cites
- 1745US2017081635A1Tumor-infiltrating lymphocytes for adoptive cell therapyH LEE MOFFITT CANCER CT & RES·Filed 2015·Application pending·0 cites
- 1841US2017044496A1Enhanced Expansion of Tumor-Infiltrating Lymphocytes for Adoptive Cell TherapyH LEE MOFFITT CANCER CT & RES·Filed 2015·Application pending·0 cites
- 1938US2020377855A1Rapid method for the culture of tumor infiltrating lymphocytesH LEE MOFFITT CANCER CT & RES·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Shari Pilon-Thomas files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →